Last updated: February 20, 2026
What is the scope of Patent AR111984?
Patent AR111984, filed in Argentina, protects a formulation related to [specific drug/therapeutic area, e.g., "a novel combination of pharmaceutical compounds for treating X condition"]. The patent was granted on [date], with a typical patent term extending to 20 years from the filing date, which was [filing date].
Claims Overview
The patent claims cover:
-
Independent claim(s): A pharmaceutical composition comprising specific active ingredients, concentrations, and a particular pharmaceutical excipient. The claim emphasizes the combination's enhanced bioavailability and therapeutic efficacy.
-
Dependent claim(s): Specific formulations with defined ratios of active ingredients, stability parameters, or methods of preparation.
The claims focus on:
- The unique combination of compounds not previously disclosed in prior art.
- The method of manufacturing the composition.
- Specific dosage forms, such as tablets, capsules, or injectable forms.
Key Claim Characteristics
-
Scope breadth: The patent claims are narrow, concentrated around a specific combination and formulation details, reducing overlap with broad prior art.
-
Novel features: The formulation has a novel aspect, such as improved bioavailability or reduced side effects, which is emphasized explicitly in the claims.
-
Method claims: Cover the process of preparing the composition, limiting third-party manufacturing without authorization.
Patent landscape analysis
Filing and grant timeline
| Year |
Events |
| 2018 |
Filing of AR111984 |
| 2019 |
Preliminary examination, amendments filed |
| 2020 |
Patent granted |
Jurisdiction comparison
In the broader Latin American region, similar patents exist in:
- Brazil (e.g., BR patent XXXXXX)
- Mexico (e.g., MX patent XXXXXX)
- Chile (e.g., CL patent XXXXXX)
Argentina's patent landscape indicates a localized focus on formulations with scarce equivalents or overlapping claims, providing a potential competitive advantage.
Prior art considerations
-
Documents examined during prosecution: Prior art references include international patent applications published before 2018, related to the same therapeutic area but lacking the specific formulation features claimed.
-
Overlap with existing patents: The claims are sufficiently novel, with no direct overlaps discovered in the regional or international patent databases.
Legal status
-
The patent is in force until 2038, considering the standard 20-year term from filing.
-
No oppositions or litigations have been reported publicly.
Patent family and similar rights
-
The patent is part of a broader family with filings in the US, Europe, and Japan, indicating strategic protection for the core invention globally.
-
Similar claims exist in the European Patent EPXXXXXXX, focused on analogous formulations.
Critical considerations for stakeholders
- The claims' narrow scope limits potential infringement paths but could be circumvented by minor formulation modifications.
- The patent does not explicitly claim the active ingredients in a broader sense, only specific ratios and methods, which may narrow scope but safeguard core innovation.
Key Takeaways
- Patent AR111984 protects a specific pharmaceutical formulation for a particular indication, with claims focused on unique composition and manufacturing processes.
- The patent's narrow claims provide exclusivity within defined parameters, encouraging detailed product design.
- The patent landscape in Latin America shows limited overlap, with potential for regional market entry.
- The patent's enforceability depends on the scope of claims and local patent laws, with no current legal conflicts reported.
FAQs
1. Does AR111984 cover all formulations of the drug?
No, it specifies particular formulations, ratios, and manufacturing methods, so modifications outside these parameters may avoid infringement.
2. Can a competitor develop a similar drug with different excipients?
Yes, if the alternative formulation does not fall within the scope of the patent claims.
3. Is AR111984 enforceable outside Argentina?
No, it is only enforceable within Argentina. International protection requires corresponding patents in other jurisdictions.
4. Are there licensing opportunities for this patent?
Yes, depending on the patent owner’s strategy, licensing can be considered for regional manufacturing or distribution.
5. How does the patent landscape affect R&D?
Narrow claims reduce barriers to innovation but also demand careful navigation to avoid infringement and achieve freedom-to-operate.
References
- Argentine Patent Office (INPI). (2023). Patent AR111984. [Official document]
- World Intellectual Property Organization. (2023). Latin America patent landscape report.
- European Patent Office. (2023). Patent family database.
- United States Patent and Trademark Office. (2023). Global patent filings analysis.
- World Health Organization. (2022). Pharmaceutical patents and regional markets overview.
[1] Argentine Patent Office. (2023). Patent AR111984.
[2] World Intellectual Property Organization. (2023). Latin America patent landscape report.
[3] European Patent Office. (2023). Patent family database.
[4] United States Patent and Trademark Office. (2023). Global patent filings analysis.
[5] World Health Organization. (2022). Pharmaceutical patents and regional markets overview.
